Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.

FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient ...

Stage 1 bladder cancer involves lamina propria invasion without detrusor involvement, requiring both eradication of index lesions and mitigation of field-change–driven multifocal recurrence risk.

Researchers from the University of Birmingham's Bladder Cancer Research Center have used a new method to detect chemical changes in the DNA in an individual's urine sample; epigenetic changes, called ...

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill ...

Ultrasound and artificial intelligence-guided algae microrobots delivered chemotherapy deep into tumors in mice, paving the ...

Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...

Bladder cancer is currently treated in its earlier stages by localized intravesical chemotherapy or immunotherapy after removing the tumor. However, recurrences occur in up to 70% of patients at 5 ...